Based on a series of studies carried out in human ACE2 transgenic mice (K18-hACE2) and Syrian hamsters, we show that immunity at the respiratory tract, acquired through either previous infection or vaccination with an in-house live attenuated virus, offers protection against antigenically distinct variants in the absence of variant spike-specific neutralizing antibodies. This evidence concerns the gene KRT18 and infection.